Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke

Withdrawn

Phase 1/2 Results N/A

Summary of Purpose

This study will evaluate the safety and efficacy of intravenous ex vivo cultured adult allogenic mesenchymal stem cells in patients with ischemic cerebral stroke. Patient will be given single intravenous dose of allogenic mesenchymal stem cells 2 million cells/Kg body weight or placebo within 10 days of stroke. Patients... Trial Stopped: Business reasons

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 May 2016.

1 Dec 2011 22 Mar 2010 1 May 2013 1 May 2013 1 Jun 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts